IRIS
BORSANI, Oscar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.161
AS - Asia 851
EU - Europa 482
SA - Sud America 274
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 41
OC - Oceania 2
Totale 2.870
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.099
BR - Brasile 222
SG - Singapore 216
CN - Cina 207
VN - Vietnam 162
HK - Hong Kong 149
IT - Italia 133
RU - Federazione Russa 105
DE - Germania 70
FR - Francia 45
FI - Finlandia 33
GB - Regno Unito 29
AR - Argentina 23
ZA - Sudafrica 19
CA - Canada 18
IE - Irlanda 17
MX - Messico 17
ID - Indonesia 15
IN - India 15
AT - Austria 12
EC - Ecuador 11
BD - Bangladesh 10
JP - Giappone 10
TR - Turchia 10
IL - Israele 9
CH - Svizzera 8
IQ - Iraq 8
NL - Olanda 8
MA - Marocco 7
MY - Malesia 6
SV - El Salvador 5
VE - Venezuela 5
AZ - Azerbaigian 4
CO - Colombia 4
ES - Italia 4
PK - Pakistan 4
SA - Arabia Saudita 4
SC - Seychelles 4
UZ - Uzbekistan 4
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LT - Lituania 3
PH - Filippine 3
PL - Polonia 3
PR - Porto Rico 3
SE - Svezia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AU - Australia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RS - Serbia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GP - Guadalupe 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LK - Sri Lanka 1
PE - Perù 1
QA - Qatar 1
UA - Ucraina 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.814
Salva come PNG Salva come JPEG
Città #
Hong Kong 141
San Jose 138
Dallas 131
Council Bluffs 122
Singapore 111
Ashburn 100
Beijing 64
Ho Chi Minh City 63
New York 40
Munich 37
Lauterbourg 32
Hanoi 31
Los Angeles 30
Shanghai 28
Moscow 25
Columbus 23
Boardman 22
Santa Clara 22
Helsinki 21
Redondo Beach 20
Dublin 17
Rome 17
Johannesburg 16
Milan 16
São Paulo 15
Buffalo 12
Catania 12
Orem 12
Turku 12
Frankfurt am Main 11
Chandler 10
Denver 10
Phoenix 10
Tokyo 10
Da Nang 9
Nuremberg 8
Rio de Janeiro 8
Brooklyn 7
Houston 7
London 7
Montreal 7
Turin 7
Haiphong 6
The Dalles 6
Baghdad 5
Chennai 5
Chicago 5
Curitiba 5
Düsseldorf 5
Jakarta 5
Pavia 5
Poplar 5
San Antonio 5
San Salvador 5
Vienna 5
Baku 4
Brasília 4
Bắc Ninh 4
Campinas 4
Can Tho 4
Mexico City 4
Miami 4
Salt Lake City 4
Seattle 4
Sorocaba 4
Ankara 3
Bishkek 3
Biên Hòa 3
Brugherio 3
Buenos Aires 3
Camaçari 3
Casablanca 3
Falkenstein 3
Florence 3
Fortaleza 3
Guangzhou 3
Hải Dương 3
Istanbul 3
Louisville 3
Lugano 3
Medford 3
Naples 3
Ninh Bình 3
North Bergen 3
Philadelphia 3
Queens 3
Quito 3
Ribeirão Preto 3
Sahāranpur 3
Salvador 3
San Francisco 3
Santiago 3
Stockholm 3
Tashkent 3
Tel Aviv 3
Viganello 3
Washington 3
Atlanta 2
Belgrade 2
Belém 2
Totale 1.650
Salva come PNG Salva come JPEG
Nome #
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 120
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis 115
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 110
COVID-19 in Patients with Hematologic Diseases 101
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 100
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms 100
Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver 97
Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation 89
Hepatic iron is the major determinant of serum ferritin in NAFLD patients 89
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms 87
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms 84
Germline MPL mutations may be a rare cause of "triple-negative" thrombocytosis 83
Clearance of Driver Mutations in Myelofibrosis 82
Erythrocytosis in congenital heart defects: hints for diagnosis and therapy from a clinical case 82
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients 80
Isolated congenital asplenia: An overlooked cause of thrombocytosis 78
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts 75
Eradication of Measurable Residual Disease in AML: A Challenging Clinical Goal 74
Breakthrough infections in MPN-COVID vaccinated patients 73
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score 70
Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy 70
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts 70
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19 67
Wandering Spleen: An Unusual Cause of Recurrent Abdominal Pain 66
Stormorken Syndrome Caused by a p.R304W STIM1 Mutation: The First Italian Patient and a Review of the Literature 66
Incidence of blast phase in myelofibrosis according to anemia severity 64
Endosteal vessel integrity: a new therapeutic goal in acute myeloid leukemia? 59
Immune Escape after Hematopoietic Stem Cell Transplantation (HSCT): From Mechanisms to Novel Therapies 58
Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms 57
The evolutionary journey from essential thrombocythaemia to acute erythroid leukaemia 56
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project 56
Long-term follow-up of recovered MPN patients with COVID-19 55
Second versus first wave of COVID-19 in patients with MPN 52
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients 51
Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment 45
Primary Budd-Chiari Syndrome 44
Antigenic-Specificity and Cytokine Profile of the T-Cell Response to Human Cytomegalovirus in Transplant Recipients 30
Characterization of a Newly Discovered Non-Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis 26
A New t(8;9) Translocation Involving the JAK2 Gene in Acute Myeloid Leukemia: A Case Report 26
Maladaptive somatic gene rescue as predisposition to JAK2 molecular abnormalities? Insights from an Israeli family 22
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study 21
CHEK2 Germline Variants in Early-Onset and Familial Myeloproliferative Neoplasms 20
Totale 2.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 1 0 0 1 5
2022/202362 4 4 0 2 2 2 0 2 15 0 27 4
2023/2024194 11 28 9 8 19 61 23 10 6 6 9 4
2024/2025556 20 23 8 2 1 19 44 24 123 33 65 194
2025/20261.522 112 116 240 278 152 29 188 53 148 94 71 41
2026/2027526 32 106 96 206 86 0 0 0 0 0 0 0
Totale 2.870